Artery Disease Clinical Trials

530 recruitingLast updated: May 13, 2026

There are 530 actively recruiting artery disease clinical trials across 66 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Seoul, South Korea, New York, New York, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Artery Disease Trials at a Glance

530 actively recruiting trials for artery disease are listed on ClinicalTrialsFinder across 6 cities in 66 countries. The largest study group is Not Applicable with 220 trials, with the heaviest enrollment activity in Seoul, New York, and Beijing. Lead sponsors running artery disease studies include Fundación EPIC, Seung-Jung Park, and China National Center for Cardiovascular Diseases.

Browse artery disease trials by phase

Treatments under study

About Artery Disease Clinical Trials

Looking for clinical trials for Artery Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Artery Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Artery Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 530 trials

Recruiting
Not Applicable

Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

Coronary Artery Disease
Chonnam National University Hospital256 enrolled8 locationsNCT06954714
Recruiting
Phase 4

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Coronary Artery Disease
University of Florida78 enrolled1 locationNCT06821191
Recruiting

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

Coronary Artery Disease (CAD)
Insel Gruppe AG, University Hospital Bern816 enrolled1 locationNCT07565805
Recruiting
Not Applicable

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Heart FailureCoronary Artery DiseaseCoronary Artery Disease (CAD)+5 more
University Medical Center Groningen358 enrolled1 locationNCT07269366
Recruiting
Not Applicable

Coronary Artery Disease Assessment Strategies in TAVI Patients

Coronary Artery DiseaseTranscatheter Aortic Valve ReplacementHeart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern546 enrolled1 locationNCT06559332
Recruiting
Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Coronary Artery Disease
Massachusetts General Hospital200 enrolled1 locationNCT05850091
Recruiting
Not Applicable

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Carotid Artery Diseases
Woo-Keun Seo1,556 enrolled1 locationNCT06276374
Recruiting
Not Applicable

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Peripheral Artery DiseaseOverweight or Obesity
Northwestern University212 enrolled7 locationsNCT04228978
Recruiting

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

AI (Artificial Intelligence)BiomarkersMyocardial Ischemia+4 more
University of Galway10,000 enrolled1 locationNCT07577609
Recruiting
Not Applicable

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Coronary Artery Disease
Teleflex150 enrolled19 locationsNCT06779630
Recruiting

Correlation of FFR CT With Invasive FFR in Multi-ethnic Cohort- a Retrospective Study

Coronary Artery Disease
Sandwell & West Birmingham Hospitals NHS Trust500 enrolled1 locationNCT06790836
Recruiting

Serranator POINT FORCE Registry

Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft
Cagent Vascular LLC500 enrolled19 locationsNCT06687590
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Phase 2

Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

Coronary Artery Disease
Research Institute of Geroprotective Technologies180 enrolled1 locationNCT07397351
Recruiting
Phase 2Phase 3

Canagliflozin Targeting Vascular Inflammation

Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting
Not Applicable

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Peripheral Artery Disease
VA Office of Research and Development225 enrolled3 locationsNCT06033924
Recruiting
Not Applicable

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

Coronary DiseaseCoronary Artery Disease
Fundación EPIC200 enrolled8 locationsNCT06736899
Recruiting

Coroflex® ISAR NEO PMCF Study

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC3,000 enrolled22 locationsNCT05698732
Recruiting
Not Applicable

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

ANOCA - Angina With Non-obstructive Coronary ArteriesINOCA (Ischemia With Non Obstructive Coronary Artery Disease)
Baylor Research Institute50 enrolled1 locationNCT06896903
Recruiting
Not Applicable

Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries

Peripheral Artery Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University180 enrolled3 locationsNCT03791970